Posts By: Gubba Group

FDA approves first saliva-based coronavirus test

April 15, 2020 Pharma

The Food and Drug Administration (FDA) approved the first saliva-based coronavirus test under its emergency powers, Rutgers University announced. The FDA deployed its emergency-use authorization...

Continue Reading

COVID-19: A wake up call for pharma stakeholders

April 15, 2020 Pharma

Dr Ajit Dangi, President & CEO, Danssen Consulting highlights the need for an action plan to insulate the pharma sector from calamities like coronavirus pandemic...

Continue Reading

Women dairy farmers ensure safe delivery of milk during coronavirus lockdown

April 15, 2020 Frozen

Most activities in cities and towns across India have come to a standstill amid the lockdown to contain the spread of the novel coronavirus. In...

Continue Reading

Lockdown blues: Meat na mila re mann ka

April 15, 2020 Frozen

The countrywide lockdown is forcing many meat eaters to adopt a herbivorous diet as supply of mutton has almost stopped while fish has become scarce...

Continue Reading

Scientists create virus-resistant tomato plants

April 15, 2020 Seed

Researchers of Valencia’s Polytechnic University (UPV) and the Spanish National Research Council (CSIC) have used tools that regulate gene expression in order to produce tomato...

Continue Reading

Gubba conducted webinar for the seed Industry to deal challenges amidst Covid circumstances

April 15, 2020 All

Gubba Seed Cold Storage has conducted a webinar on April 13th on the topic “ Covid-19 Seed industry challenges & how to overcome”. The session...

Continue Reading

Lockdown curbs hit seed processing

April 15, 2020 Seed

Telangana is seed hub with over 400 companies operating from the State The farm sector across India, as also elsewhere across the world, is likely...

Continue Reading

India ‘considering’ Trump’s plea on supply of key drug

April 8, 2020 Pharma

India is considering a request by US President Donald Trump to relax the ban on export of hydroxychloroquine, the anti-malaria drug which, as Trump has...

Continue Reading

Gilead To Donate 1.5M Doses Of Experimental Coronavirus Treatment: ‘The Right Thing To Do’

April 8, 2020 Pharma

Gilead Sciences, Inc. is donating 1.5 million doses of remdesivir, its investigational drug for COVID-19, for compassionate use, expanded access and clinical trials, Chairman and...

Continue Reading